Spero Therapeutics

(NASDAQ) SPRO

Current Price$2.72

Market Cap$141.26M

Since IPO (2017)-79%

5 Year-82%

1 Year+254%

1 Month-12%

Spero Therapeutics Financials at a Glance

Market Cap

$141.26M

Revenue (TTM)

$54.77M

Net Income (TTM)

$22.44M

EPS (TTM)

$0.12

P/E Ratio

20.50

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$2.72

Volume

63,626

Open

$2.42

Price

$2.72

Volume

63,626

Open

$2.42

Previous Close

$2.72

Daily Range

$2.37 - $2.74

52-Week Range

$0.63 - $3.22

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$2.72

Volume

63,626

Open

$2.42

Previous Close

$2.72

Daily Range

$2.37 - $2.74

52-Week Range

$0.63 - $3.22

SPRO News

Why Spero Therapeutics Stock Is Up 15% Today

James BrumleyJul 1, 2021

Why Spero Therapeutics Shares Are Sliding Today

Keith SpeightsSep 11, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spero Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Esther Rajavelu, MBA

Website

www.sperotherapeutics.com

Headquarters

Cambridge, MA 02139, US

SPRO Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

13%

Net Income Margin

41%

Return on Equity

16%

Return on Capital

13%

Return on Assets

38%

Earnings Yield

4.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$141.26M

Shares Outstanding

57.89M

Volume

63.63K

Avg. Volume

395.62K

Financials (TTM)

Gross Profit

$59.62M

Operating Income

$24.00K

EBITDA

$24.00K

Operating Cash Flow

$12.62M

Capital Expenditure

$0.00

Free Cash Flow

$12.62M

Cash & ST Invst.

$40.27M

Total Debt

$2.90M

Spero Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$258.00K

-95.6%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$141.26M

N/A

Market Cap/Employee

$4.41M

N/A

Employees

N/A

Net Income

$0.00

+100.0%

EBITDA

$7.54M

+48.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$53.66M

+19.4%

Accounts Receivable

$44.00K

-99.8%

Inventory

$0.00

N/A

Long Term Debt

$507.00K

-76.6%

Short Term Debt

$1.97M

+9.6%

Return on Assets

38.02%

N/A

Return on Invested Capital

13.39%

N/A

Free Cash Flow

$15.86M

+496.4%

Operating Cash Flow

$15.86M

+496.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABOSAcumen Pharmaceuticals, Inc.

ABOSAcumen Pharmaceuticals, Inc.$2.39-4.02%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$11.98-1.40%

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.51+0.00%

SEERSeer, Inc.

SEERSeer, Inc.$1.75-1.13%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.20+0.00%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$8.03+3.48%

INOInovio Pharmaceuticals, Inc.

INOInovio Pharmaceuticals, Inc.$1.36+1.49%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.46+0.07%

AIIORobo.ai

AIIORobo.ai$5.65+1.16%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.66-0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.66-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.07+0.02%

FRMIFermi

FRMIFermi$7.36+0.23%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.07-0.02%

Questions About SPRO

What is the current price of Spero Therapeutics?

Spero Therapeutics is trading at $2.72 per share.

What is the 52-week range for Spero Therapeutics?

Over the past 52 weeks, Spero Therapeutics has traded between $0.63 and $3.22.

How much debt does Spero Therapeutics have?

As of the most recent reporting period, Spero Therapeutics reported total debt of $2.47M.

How much cash does Spero Therapeutics have on hand?

Spero Therapeutics reported $56.13M in cash and cash equivalents in its most recent financial results.

What is Spero Therapeutics’s dividend yield?

Spero Therapeutics does not currently have a dividend yield.

Spero Therapeutics

Spero Therapeutics Financials at a Glance

SPRO News

Why Spero Therapeutics Stock Is Up 15% Today

Why Spero Therapeutics Shares Are Sliding Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Spero Therapeutics

SPRO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Spero Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPRO

What is the current price of Spero Therapeutics?

What is the 52-week range for Spero Therapeutics?

How much debt does Spero Therapeutics have?

How much cash does Spero Therapeutics have on hand?

What is Spero Therapeutics’s dividend yield?

Premium Investing Services